Immune checkpoints and immunotherapy in non-small cell lung cancer: Novel study progression, challenges and solutions

Lung cancer is the most common type of cancer with the highest mortality rate worldwide. Non-small cell lung cancer (NSCLC) accounts for ~85% of the total number of lung cancer cases. In the past two decades, immunotherapy has become a more promising treatment method than traditional treatments (sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Lin-Rui, Li, Jia-Xin, Tang, Ling, Li, Run-Ze, Yang, Jia-Shun, Sun, Ao, Leung, Elaine Lai-Han, Yan, Pei-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456509/
https://www.ncbi.nlm.nih.gov/pubmed/34594428
http://dx.doi.org/10.3892/ol.2021.13048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456509/
https://www.ncbi.nlm.nih.gov/pubmed/34594428
http://dx.doi.org/10.3892/ol.2021.13048

Ejemplares similares